Status:

COMPLETED

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome

Lead Sponsor:

Washington University School of Medicine

Conditions:

HIV (Human Immunodeficiency Virus)

Metabolic Syndrome

Eligibility:

FEMALE

18-60 years

Phase:

NA

Brief Summary

Obese HIV-positive women with Metabolic Syndrome (HIV-MS) and obese HIV-negative women with Metabolic Syndrome will be studied before and after achieving moderate (6%-8%) diet-induced weight loss. The...

Eligibility Criteria

Inclusion

  • Sedentary
  • Obese
  • Have either dyslipidemia (HDL \< 50 or triglycerides \> 150), waist circumference \> 88cm, and impaired glucose tolerance or homeostasis model assessment value of \> 3
  • Subjects with HIV-MS must have been receiving HAART for \> 6 months

Exclusion

  • Medication changes in the last 3 months
  • Diabetes mellitus
  • Medical problems that in the opinion of the principal investigator may interfere with patient safety
  • Substance abuse

Key Trial Info

Start Date :

February 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2014

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00857298

Start Date

February 1 2009

End Date

July 1 2014

Last Update

February 16 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome | DecenTrialz